Autor(es): Castilho, Marcelo Santos ; Postigo, Matheus P. ; Pereira, Humberto M. ; Oliva, Glaucius ; Andricopulo, Adriano D. ; Castilho, Marcelo Santos ; Postigo, Matheus P. ; Pereira, Humberto M. ; Oliva, Glaucius ; Andricopulo, Adriano D.
Data: 2012
Origem: Oasisbr
Assunto(s): Neglected tropical diseases; Schistosomiasis; Enzyme inhibition; Selectivity
Trabalho completo: acesso restrito, p. 1421–1427
Submitted by Bruna Lessa (lessbruna@gmail.com) on 2012-05-29T16:52:18Z No. of bitstreams: 1 (39)1-s2.0-S096808961000043X-main.pdf: 998932 bytes, checksum: 90bd5773640cb0d48d8c9ddf633bc2d8 (MD5)
Made available in DSpace on 2012-05-29T16:52:18Z (GMT). No. of bitstreams: 1 (39)1-s2.0-S096808961000043X-main.pdf: 998932 bytes, checksum: 90bd5773640cb0d48d8c9ddf633bc2d8 (MD5) Previous issue date: 2010-02-15
Selectivity plays a crucial role in the design of enzyme inhibitors as novel antiparasitic agents, particularly in cases where the target enzyme is also present in the human host. Purine nucleoside phosphorylase from Schistosoma mansoni (SmPNP) is an attractive target for the discovery of potential antischistosomal agents. In the present work, kinetic studies were carried out in order to determine the inhibitory potency, mode of action and enzyme selectivity of a series of inhibitors of SmPNP. In addition, crystallographic studies provided important structural insights for rational inhibitor design, revealing consistent structural differences in the binding mode of the inhibitors in the active sites of the SmPNP and human PNP (HsPNP) structures. The molecular information gathered in this work should be useful for future medicinal chemistry efforts in the design of new inhibitors of SmPNP having increased affinity and selectivity.
